Selenium and signal transduction: roads to cell death and anti-tumour activity

A Ghose1, J Fleming, P R Harrison

  • 1CRC Beatson Laboratories, The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow, G61 1BD, UK.

Biofactors (Oxford, England)
|September 25, 2001
PubMed

Insights

Selenium compounds may prevent oral cancer by inducing apoptosis, or programmed cell death, in cancer cells. This process involves the c-Jun N-terminal kinase (JNK) pathway, a key regulator of cell death.

Area of Science:

  • Oncology
  • Molecular Biology
  • Nutritional Science

Background:

  • Growing evidence suggests a link between selenium intake and reduced cancer incidence.
  • Selenium's potential chemopreventive effects are attributed to mechanisms like inhibiting cell proliferation and inducing apoptosis.
  • Mitogen-activated protein kinase (MAPK) pathways are critical regulators of cell death.

Purpose of the Study:

  • To investigate the role of MAPK pathways in selenium-induced apoptosis in oral cancer.
  • To compare the sensitivity of oral carcinoma cells and normal oral mucosa to selenium compounds.

Main Methods:

  • Primary cultures of oral cancer cells and normal oral mucosa from biopsy material were used.
  • Cells were treated with specific selenium compounds.
  • Apoptosis induction, Fas ligand expression, and MAPK pathway activation (including JNK) were analyzed.

Main Results:

  • Oral carcinoma cells exhibited increased sensitivity to apoptosis upon treatment with certain selenium compounds compared to normal oral mucosa.
  • Selenium-induced apoptosis was associated with the induction of Fas ligand.
  • Signal transduction studies revealed alterations in MAPK pathways, with JNK pathway activation being crucial for selenium's apoptotic effect.

Conclusions:

  • Selenium compounds demonstrate potential in inducing apoptosis specifically in oral cancer cells.
  • The JNK pathway plays a significant role in mediating selenium-induced apoptosis in oral cancer.
  • These findings support selenium's chemopreventive potential against oral cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...